Fennec Pharmaceuticals Inc
NASDAQ:FENC
Income Statement
Earnings Waterfall
Fennec Pharmaceuticals Inc
Revenue
|
21.3m
USD
|
Cost of Revenue
|
-1.3m
USD
|
Gross Profit
|
20m
USD
|
Operating Expenses
|
-32.8m
USD
|
Operating Income
|
-12.8m
USD
|
Other Expenses
|
-3.3m
USD
|
Net Income
|
-16m
USD
|
Income Statement
Fennec Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
3
+109%
|
7
+103%
|
13
+100%
|
21
+63%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
3
+109%
|
6
+105%
|
12
+100%
|
20
+61%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(13)
|
(12)
|
(13)
|
(14)
|
(14)
|
(18)
|
(18)
|
(19)
|
(18)
|
(17)
|
(17)
|
(16)
|
(17)
|
(21)
|
(24)
|
(27)
|
(30)
|
(29)
|
(33)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(9)
|
(10)
|
(13)
|
(13)
|
(13)
|
(12)
|
(11)
|
(12)
|
(12)
|
(13)
|
(17)
|
(21)
|
(25)
|
(29)
|
(29)
|
(33)
|
|
Research & Development |
(1)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(6)
|
(6)
|
(5)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(2)
|
(1)
|
(0)
|
(0)
|
|
Operating Income |
(2)
N/A
|
(2)
N/A
|
(2)
N/A
|
(3)
-29%
|
(3)
-15%
|
(3)
+3%
|
(2)
+14%
|
(2)
+12%
|
(2)
+11%
|
(2)
N/A
|
(2)
-8%
|
(2)
-11%
|
(3)
-26%
|
(3)
-11%
|
(4)
-24%
|
(6)
-41%
|
(7)
-24%
|
(8)
-15%
|
(9)
-15%
|
(10)
-7%
|
(10)
-6%
|
(11)
-9%
|
(13)
-19%
|
(12)
+7%
|
(13)
-4%
|
(14)
-9%
|
(14)
0%
|
(18)
-28%
|
(18)
+2%
|
(19)
-6%
|
(18)
+5%
|
(16)
+9%
|
(17)
-5%
|
(16)
+8%
|
(17)
-7%
|
(21)
-22%
|
(23)
-9%
|
(24)
-8%
|
(24)
+1%
|
(17)
+29%
|
(13)
+25%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
4
|
5
|
(3)
|
0
|
1
|
4
|
4
|
3
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
2
N/A
|
3
+50%
|
(5)
N/A
|
(2)
+47%
|
(2)
+11%
|
1
N/A
|
2
+48%
|
1
-28%
|
(1)
N/A
|
(1)
-89%
|
(2)
-44%
|
(2)
-21%
|
(3)
-28%
|
(3)
-14%
|
(4)
-28%
|
(6)
-46%
|
(7)
-19%
|
(8)
-11%
|
(9)
-13%
|
(9)
-5%
|
(10)
-8%
|
(11)
-11%
|
(13)
-20%
|
(12)
+7%
|
(13)
-5%
|
(14)
-9%
|
(14)
-1%
|
(18)
-31%
|
(18)
+2%
|
(19)
-5%
|
(18)
+4%
|
(16)
+11%
|
(17)
-7%
|
(16)
+6%
|
(17)
-7%
|
(21)
-22%
|
(24)
-11%
|
(26)
-10%
|
(26)
-1%
|
(20)
+24%
|
(16)
+21%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
2
|
3
|
(5)
|
(2)
|
(2)
|
1
|
2
|
1
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(6)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(11)
|
(13)
|
(12)
|
(13)
|
(14)
|
(14)
|
(18)
|
(18)
|
(19)
|
(18)
|
(16)
|
(17)
|
(16)
|
(17)
|
(21)
|
(24)
|
(26)
|
(26)
|
(20)
|
(16)
|
|
Net Income (Common) |
2
N/A
|
3
+50%
|
(5)
N/A
|
(2)
+47%
|
(2)
+11%
|
1
N/A
|
2
+48%
|
1
-28%
|
(1)
N/A
|
(1)
-89%
|
(2)
-44%
|
(2)
-21%
|
(3)
-28%
|
(3)
-14%
|
(4)
-28%
|
(6)
-46%
|
(7)
-19%
|
(8)
-11%
|
(9)
-13%
|
(9)
-5%
|
(10)
-8%
|
(11)
-11%
|
(13)
-20%
|
(12)
+7%
|
(13)
-5%
|
(14)
-9%
|
(14)
-1%
|
(18)
-31%
|
(18)
+2%
|
(19)
-5%
|
(18)
+4%
|
(16)
+11%
|
(17)
-7%
|
(16)
+6%
|
(17)
-7%
|
(21)
-22%
|
(24)
-11%
|
(26)
-10%
|
(26)
-1%
|
(20)
+24%
|
(16)
+21%
|
|
EPS (Diluted) |
0.11
N/A
|
0.3
+173%
|
-0.46
N/A
|
-0.21
+54%
|
-0.22
-5%
|
0.1
N/A
|
0.16
+60%
|
0.12
-25%
|
-0.06
N/A
|
-0.12
-100%
|
-0.16
-33%
|
-0.15
+6%
|
-0.22
-47%
|
-0.24
-9%
|
-0.29
-21%
|
-0.37
-28%
|
-0.47
-27%
|
-0.42
+11%
|
-0.47
-12%
|
-0.48
-2%
|
-0.52
-8%
|
-0.56
-8%
|
-0.66
-18%
|
-0.61
+8%
|
-0.64
-5%
|
-0.7
-9%
|
-0.6
+14%
|
-0.72
-20%
|
-0.76
-6%
|
-0.75
+1%
|
-0.69
+8%
|
-0.61
+12%
|
-0.67
-10%
|
-0.62
+7%
|
-0.66
-6%
|
-0.81
-23%
|
-0.9
-11%
|
-0.99
-10%
|
-1.01
-2%
|
-0.77
+24%
|
-0.6
+22%
|